Business Wire

MA-4AIR

Share
4AIR Launches Assure SAF Registry to Track and Validate Sustainable Aviation Fuel

4AIR, which helps companies offset their emissions, use Sustainable Aviation Fuel (SAF), and drive technological change, today announced the launch of Assure SAF Registry, a blockchain-based web registry designed to document, trace and account for the sustainability attributes of Sustainable Aviation Fuel (SAF).

The Assure SAF Registry provides complete transparency about the type of SAF purchased, the feedstock used, the blend of the fuel, and any sustainability certifications earned or regulatory programs for which the fuel may be eligible. The registry is designed for both physical and book and claim supply chains of SAF and will simplify inventory accounting and prevent double-counting of benefits. All while protecting suppliers’ commercially sensitive and confidential data. By uniquely addressing a SAF tracking need for fuel suppliers, FBOs, airlines, and operators, within the physical supply chain, the registry can unlock the opportunity for a robust book and claim tracking system as well.

“Most SAF today comes from one to two different feedstocks with a narrow range of blends. As SAF expands to new feedstocks and higher blends, transparency about the fuel and where it came from will be critical in efforts to scale its use across the industry, including both business and commercial aviation,” said Kennedy Ricci, President of 4AIR. “Assure SAF Registry will provide a key piece of infrastructure for the transparent scale-up of SAF in aviation, providing transparency to emission claims around SAF while maximizing the value for the operator.”

Leveraging the expertise gained through the documentation of 5.8 million gallons of SAF over the last 2 years, 4AIR created a registry that addresses the most challenging pain points found when tracing the usage of SAF. Usually, SAF is co-mingled in airport pipelines or fuel farms under mass balance or book and claim chains of custody, making it laborious to document, particularly when trying to retain information for regulatory claims from the use of the fuel.

The Assure SAF Registry serializes each unit of fuel and is linked to a specific owner and batch of SAF. This ensures that only one owner can ever claim a specific quantity of fuel and that sustainability characteristics are consistently and accurately communicated through various owners, providing confidence in the ownership and emissions accounting up and down the SAF supply chain.

Pilot programs will help the platform to automate integrations with supplier systems, eliminating the need for much of the manual reporting and accounting. In addition, a pilot program with the Roundtable on Sustainable Biomaterials (RSB) will seek recognition within the RSB Book & Claim System and work towards ecosystem harmonization and a credible claim for customers.

About 4AIR

4AIR is an aviation industry pioneer offering sustainability solutions beyond just simple carbon neutrality. Its industry-first framework seeks to address climate impacts of all types and provides a simplified and verifiable path for aviation industry participants to achieve meaningful aircraft emissions counteraction and reduction. The 4AIR framework offers four levels, each with specific, science-based goals, independently verified results, and progressively greater impacts on sustainability that make it easy for private aviation users to pursue sustainability through access to carbon markets, use of Sustainable Aviation Fuel, support for new technologies and other strategies. For more information, visit us at www.4air.aero.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230522005450/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Mandate of BaFin’s special commissioner at flatexDEGIRO terminated18.10.2024 17:25:00 CEST | Press release

Mandate of BaFin’s special commissioner at flatexDEGIRO terminated The mandate of the BaFin’s special commissioner at flatexDEGIRO Bank AG (the “Company”) was terminated on September 30, 2024, following the successful elimination of the serious deficiencies identified in the 2022 special audit by the Company and a positive review by the special commissioner. flatexDEGIRO AG made this announcement on October 18, 2024, following a corresponding decision by the German Federal Financial Supervisory Authority (BaFin). Oliver Behrens, CEO of flatexDEGIRO, said: “We have realigned and sustainably strengthened our organizational structures and processes in constructive cooperation with BaFin and the special commissioner. We are thereby closing a regulatory chapter and again increase our focus on our customers and important growth projects. My special thanks go to all employees who, under the leadership of Steffen Jentsch, member of the bank's management board, have made it possible to reach th

Biological Lattice Industries (BLI) Secures $1.8 Million Pre-Seed Funding Led by Uni.Fund to Democratize Biofabrication18.10.2024 16:00:00 CEST | Press release

Biological Lattice Industries Corp. (BLI), a leading innovator in biofabrication and life sciences R&D, today announced the successful closing of a $1.8 million pre-seed investment round led by Greek venture capital firm Uni.Fund. In conjunction with this funding announcement , BLI is introducing its first all-in-one solution for biofabrication: BioLoom™, BLI's advanced multi-tool 3D bioprinter and Loominus Studio™, its unified software platform designed to revolutionize biofabrication workflows. BLI, a US startup with R&D operations in Greece, aims to radically simplify biofabrication for the global R&D community by providing intelligent, automated tools that streamline the design, fabrication, and testing of biomaterials. Biomaterials are critical for a wide array of biological applications. The applications range from advanced 3D cell culture systems for human biology emulation to the next-generation of resorbable medical devices and drug delivery systems for tissue trauma repair. “

Gurobi Brings Decision Intelligence Summit to Amsterdam18.10.2024 15:00:00 CEST | Press release

The event will unite industry leaders from across the EMEAI region for two days of in-person learning and networking. Gurobi Optimization, LLC, the leader in decision intelligence technology, is set to host the first annual EMEAI Decision Intelligence Summit (“Gurobi Summit”) at Amsterdam’s Capital C on November 5-6, 2024. Following the success of last month’s inaugural summit for the Americas in Las Vegas, the EMEAI Summit will bring together operations researchers, data scientists, and business leaders from across the region to explore the latest advancements in mathematical optimization and decision intelligence. The Gurobi Summit will feature special presentations from companies such as Accenture and ICRON. Several of the company’s partners—including Decide4AI, Decision Labs, LTPLabs, and ORMAE—will also be present to showcase their solutions and insights. The two-day event will be packed with informative presentations, exciting customer case studies, and interactive learning oppor

Vertex to Present Phase 3 Data Highlighting Suzetrigine’s Potential as a First-in-Class, Highly Selective Pain Signal Inhibitor at the American Society of Anesthesiologists Annual Meeting18.10.2024 14:00:00 CEST | Press release

-- Phase 3 abstract selected for presentation in “Best Abstract” session -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the company will present its pivotal Phase 3 data on suzetrigine, an investigational, oral, highly selective NaV1.8 pain signal inhibitor for the treatment of moderate-to-severe acute pain, at the annual meeting of the American Society of Anesthesiologists (ASA), taking place from October 18-22, 2024 in Philadelphia, Pennsylvania. Abstract A1187 — “Randomized, Placebo-Controlled, Phase 3 Trials of Suzetrigine, a Non-Opioid, Pain Signal Inhibitor for Treatment of Acute Pain After Abdominoplasty or Bunionectomy” will be presented as an oral presentation on Sunday, October 20, during the “Best Abstract” session, which runs from 8:00-11:00 a.m. ET, as well as the Education session which runs on Monday, October 21, from 1:30-2:30 p.m. ET. Abstract A2074 — “A Phase 3, Single-Arm Study of Suzetrigine, a Non-Opioid, Pain Signal Inhibitor For Treatm

MDPI Champions Open Access for Global Progress18.10.2024 10:00:00 CEST | Press release

During International Open Access Week 2024, MPDI promotes open scholarship to accelerate scientific discovery and advance social outcomes MDPI, a leading open access (OA) publisher, is proud to announce its participation in International Open Access Week 2024, 21–27 October. This year’s theme, “Community over Commercialization”, resonates with MDPI’s commitment to publishing insights for everyone, regardless of background. OA Week is a valuable opportunity to inspire engagement with the open access movement and to advocate for more sustainable and inclusive scholarly communication. This mission, shared by MDPI, helps to ensure that all communities have the means to participate in shaping global futures. To support these aims, MDPI will be sharing a variety of digital resources discussing quality and ethics in OA publishing, the tools we provide to support researchers, and the benefits of OA and open research. For more information on MDPI’s initiatives, please visit our website. By work

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye